Measures outcomes endometrial cancer vulvar neoplasms. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy5

Endometrium Cell Line, Tumor Tumor Cells, Cultured Myometrium Lymph Nodes

Organisms1

Diseases70

Vulvar Neoplasms Endometrial Neoplasms Carcinoma, Endometrioid Neoplasms Endometrial Hyperplasia Pancreatic Neoplasms Ovarian Neoplasms Uterine Neoplasms Neoplasm Invasiveness Breast Neoplasms Lung Neoplasms Adenocarcinoma Cystadenocarcinoma, Serous Carcinoma Genital Neoplasms, Female Prostatic Neoplasms Neoplasms, Multiple Primary Neoplasm Metastasis Genetic Predisposition to Disease Neoplasms, Second Primary Colonic Neoplasms Neoplasm Recurrence, Local Stomach Neoplasms Colorectal Neoplasms, Hereditary Nonpolyposis Adenocarcinoma, Clear Cell Cystadenocarcinoma, Papillary Skin Neoplasms Disease Progression Colorectal Neoplasms Uterine Cervical Neoplasms Neoplasms, Cystic, Mucinous, and Serous Adenocarcinoma, Mucinous Kidney Neoplasms Liver Neoplasms Adenocarcinoma, Papillary Urinary Bladder Neoplasms Thyroid Neoplasms Carcinoma, Squamous Cell Neoplasms, Hormone-Dependent Mixed Tumor, Mullerian Gastrointestinal Neoplasms Neoplasms, Radiation-Induced Carcinoma, Papillary Precancerous Conditions Bone Neoplasms Neoplasms, Glandular and Epithelial Cell Transformation, Neoplastic Obesity Rectal Neoplasms Vaginal Neoplasms Uterine Hemorrhage Microsatellite Instability Carcinosarcoma Mouth Neoplasms Carcinoma, Pancreatic Ductal Neoplasms, Experimental Recurrence Carcinoma, Non-Small-Cell Lung Testicular Neoplasms Esophageal Neoplasms Adenoma Head and Neck Neoplasms Peritoneal Neoplasms Postoperative Complications Mixed Tumor, Mesodermal Carcinoma, Adenosquamous Neovascularization, Pathologic Myeloproliferative Disorders Pelvic Neoplasms Lymphoma

Chemicals and Drugs41

Tumor Markers, Biological Neoplasm Proteins Tamoxifen Estrogens DNA, Neoplasm Receptors, Progesterone Antineoplastic Agents, Hormonal Progestins Receptors, Estrogen Antineoplastic Agents RNA, Messenger Antigens, Neoplasm Estrogen Antagonists Contraceptives, Oral PTEN Phosphohydrolase MutS Homolog 2 Protein Cancer Vaccines Estrogen Receptor alpha Tumor Suppressor Protein p53 Estrogen Receptor Modulators RNA, Small Interfering Selective Estrogen Receptor Modulators Receptor, erbB-2 Nuclear Proteins Tumor Suppressor Proteins Paclitaxel DNA-Binding Proteins RNA, Neoplasm Proto-Oncogene Proteins Adaptor Proteins, Signal Transducing Antibodies, Monoclonal Cisplatin Proto-Oncogene Proteins c-akt Estradiol MicroRNAs Anticarcinogenic Agents Toremifene Prostate-Specific Antigen TOR Serine-Threonine Kinases Raloxifene CA-125 Antigen

Analytical, Diagnostic and Therapeutic Techniques and Equipment78

Treatment Outcome Risk Factors Prognosis Retrospective Studies Neoplasm Staging Follow-Up Studies Prospective Studies Early Detection of Cancer Hysterectomy Risk Survival Rate Case-Control Studies Survival Analysis Cohort Studies Risk Assessment Odds Ratio Immunohistochemistry Incidence Pregnancy Outcome Registries Logistic Models Reproducibility of Results Multivariate Analysis Sensitivity and Specificity Predictive Value of Tests Estrogen Replacement Therapy Kaplan-Meier Estimate Reverse Transcriptase Polymerase Chain Reaction Neoplasm Grading Body Mass Index Salpingectomy Questionnaires Antineoplastic Combined Chemotherapy Protocols Gene Expression Profiling Combined Modality Therapy Confidence Intervals Disease-Free Survival Blotting, Western Neoplasm Transplantation SEER Program Chemotherapy, Adjuvant Lymph Node Excision Polymerase Chain Reaction Xenograft Model Antitumor Assays Immunoenzyme Techniques Oligonucleotide Array Sequence Analysis Obesity Clinical Trials as Topic Hormone Replacement Therapy Chi-Square Distribution Radiotherapy, Adjuvant Severity of Illness Index Analysis of Variance Neoplasms, Experimental Regression Analysis Tissue Array Analysis Tomography, X-Ray Computed Biopsy Gynecologic Surgical Procedures Pilot Projects Cross-Sectional Studies Magnetic Resonance Imaging Molecular Targeted Therapy Proportional Hazards Models Radiotherapy Genetic Testing Transplantation, Heterologous Randomized Controlled Trials as Topic Drug Screening Assays, Antitumor Tumor Burden Prevalence Models, Biological Research Design DNA Mutational Analysis Laparoscopy Dilatation and Curettage Models, Statistical Longitudinal Studies

Psychiatry and Psychology1

Phenomena and Processes46

Risk Gene Expression Regulation, Neoplastic Odds Ratio Time Factors Postmenopause Genetic Predisposition to Disease Pregnancy Outcome Sensitivity and Specificity Mutation Genotype Body Mass Index DNA Methylation Cell Proliferation Germ-Line Mutation Drug Resistance, Neoplasm Pregnancy Polymorphism, Genetic Menopause Apoptosis Obesity Microsatellite Repeats Parity Dose-Response Relationship, Drug Gene Silencing Cell Growth Processes Premenopause Chi-Square Distribution Microsatellite Instability Diet Cell Survival Down-Regulation Signal Transduction Cell Division Polymorphism, Single Nucleotide Cell Cycle Genes, Tumor Suppressor Promoter Regions, Genetic Alleles Phenotype Base Sequence Cell Movement Algorithms DNA Mismatch Repair Gene Expression Genes, Neoplasm Up-Regulation

Disciplines and Occupations3

Outcome Assessment (Health Care)Immunohistochemistry Research Design

Anthropology, Education, Sociology and Social Phenomena5

Quality of Life National Cancer Institute (U.S.)Age Distribution Socioeconomic Factors Survival

Technology, Industry, Agriculture1

Humanities1

Quality of Life

Information Science8

Survival Rate Incidence Registries Questionnaires SEER Program Prevalence Base Sequence Algorithms

Named Groups3

Survivors Infant, Newborn European Continental Ancestry Group

Health Care47

Treatment Outcome Risk Factors Retrospective Studies Outcome Assessment (Health Care)Follow-Up Studies Prospective Studies Risk Survival Rate Case-Control Studies Survival Analysis Cohort Studies Risk Assessment Odds Ratio Age Factors Incidence Registries Logistic Models Reproducibility of Results Multivariate Analysis Sensitivity and Specificity Predictive Value of Tests Kaplan-Meier Estimate Body Mass Index Questionnaires Confidence Intervals Disease-Free Survival Outcome and Process Assessment (Health Care)SEER Program Clinical Trials as Topic Parity Chi-Square Distribution Severity of Illness Index Analysis of Variance Regression Analysis Pilot Projects Cross-Sectional Studies Proportional Hazards Models National Cancer Institute (U.S.)Sex Factors Genetic Testing Randomized Controlled Trials as Topic Age Distribution Socioeconomic Factors Confounding Factors (Epidemiology)Prevalence Models, Statistical Longitudinal Studies

Geographicals6

United States Sweden China Japan Great Britain Italy

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Vulvar Neoplasms Endometrial Neoplasms Carcinoma, Endometrioid Treatment Outcome Neoplasms Risk Factors Prognosis Endometrial Hyperplasia Retrospective Studies Pancreatic Neoplasms Ovarian Neoplasms Outcome Assessment (Health Care)Neoplasm Staging Uterine Neoplasms Follow-Up Studies Prospective Studies Neoplasm Invasiveness Breast Neoplasms Early Detection of Cancer Hysterectomy Endometrium Lung Neoplasms Tumor Markers, Biological Risk Adenocarcinoma Survival Rate Case-Control Studies Gene Expression Regulation, Neoplastic Survival Analysis Cohort Studies Cystadenocarcinoma, Serous United States Risk Assessment Carcinoma Genital Neoplasms, Female Neoplasm Proteins Odds Ratio Tamoxifen Cell Line, Tumor Immunohistochemistry Prostatic Neoplasms Time Factors Neoplasms, Multiple Primary Age Factors Estrogens Neoplasm Metastasis Incidence Postmenopause Genetic Predisposition to Disease Neoplasms, Second Primary Colonic Neoplasms Pregnancy Outcome Neoplasm Recurrence, Local DNA, Neoplasm Stomach Neoplasms Colorectal Neoplasms, Hereditary Nonpolyposis Registries Adenocarcinoma, Clear Cell Logistic Models Receptors, Progesterone Cystadenocarcinoma, Papillary Skin Neoplasms Reproducibility of Results Disease Progression Antineoplastic Agents, Hormonal Colorectal Neoplasms Multivariate Analysis Sensitivity and Specificity Uterine Cervical Neoplasms Progestins Predictive Value of Tests Estrogen Replacement Therapy Kaplan-Meier Estimate Receptors, Estrogen Neoplasms, Cystic, Mucinous, and Serous Mice, Nude Reverse Transcriptase Polymerase Chain Reaction Mutation Antineoplastic Agents Genotype Neoplasm Grading Body Mass Index Adenocarcinoma, Mucinous RNA, Messenger Quality of Life Salpingectomy Questionnaires Kidney Neoplasms Antineoplastic Combined Chemotherapy Protocols Liver Neoplasms DNA Methylation Adenocarcinoma, Papillary Gene Expression Profiling Urinary Bladder Neoplasms Thyroid Neoplasms Combined Modality Therapy Antigens, Neoplasm Confidence Intervals Cell Proliferation Carcinoma, Squamous Cell

No FAQ available that match "measures outcomes endometrial cancer vulvar neoplasms"